TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
ko00230	Purine metabolism	0.00199416570193582	-6.21752951062641	174	4	0.181818181818182	22	6908	5631,10846,5139,4907	PRPS1,PDE10A,PDE3A,NT5E
hsa00230	Purine metabolism	0.00199416570193582	-6.21752951062641	174	4	0.181818181818182	22	6908	10846,5631,5139,4907	PDE10A,PRPS1,PDE3A,NT5E
hsa04512	ECM-receptor interaction	0.00249921859256424	-5.99177715894027	87	3	0.136363636363636	22	6908	3910,3691,960	LAMA4,ITGB4,CD44
ko04512	ECM-receptor interaction	0.00249921859256424	-5.99177715894027	87	3	0.136363636363636	22	6908	3910,3691,960	LAMA4,ITGB4,CD44
hsa04340	Hedgehog signaling pathway	0.0112336138368159	-4.48884475996726	51	2	0.0909090909090909	22	6908	7546,51384	ZIC2,WNT16
ko04340	Hedgehog signaling pathway	0.0112336138368159	-4.48884475996726	51	2	0.0909090909090909	22	6908	7546,51384	ZIC2,WNT16
ko03320	PPAR signaling pathway	0.0199687412422095	-3.91358716597922	69	2	0.0909090909090909	22	6908	5468,51129	PPARG,ANGPTL4
hsa03320	PPAR signaling pathway	0.0199687412422095	-3.91358716597922	69	2	0.0909090909090909	22	6908	5468,51129	PPARG,ANGPTL4
hsa05205	Proteoglycans in cancer	0.0255149192505604	-3.66849192925426	203	3	0.136363636363636	22	6908	817,51384,960	CAMK2D,WNT16,CD44
ko05205	Proteoglycans in cancer	0.0255149192505604	-3.66849192925426	203	3	0.136363636363636	22	6908	817,51384,960	CAMK2D,WNT16,CD44
hsa05032	Morphine addiction	0.0334205621411018	-3.3985839354566	91	2	0.0909090909090909	22	6908	10846,5139	PDE10A,PDE3A
ko05032	Morphine addiction	0.0334205621411018	-3.3985839354566	91	2	0.0909090909090909	22	6908	10846,5139	PDE10A,PDE3A
hsa05200	Pathways in cancer	0.0344903042435615	-3.36707703086146	397	4	0.181818181818182	22	6908	3910,2254,51384,5468	LAMA4,FGF9,WNT16,PPARG
hsa04916	Melanogenesis	0.0397110552969962	-3.22612565909775	100	2	0.0909090909090909	22	6908	817,51384	CAMK2D,WNT16
ko04916	Melanogenesis	0.0397110552969962	-3.22612565909775	100	2	0.0909090909090909	22	6908	817,51384	CAMK2D,WNT16
hsa05166	HTLV-I infection	0.0469463555859143	-3.05874969964392	258	3	0.136363636363636	22	6908	4488,4487,51384	MSX2,MSX1,WNT16
ko05166	HTLV-I infection	0.0469463555859143	-3.05874969964392	258	3	0.136363636363636	22	6908	4488,4487,51384	MSX2,MSX1,WNT16
hsa04114	Oocyte meiosis	0.0487410891835535	-3.02123288422406	112	2	0.0909090909090909	22	6908	817,9748	CAMK2D,SLK
ko04114	Oocyte meiosis	0.0487410891835535	-3.02123288422406	112	2	0.0909090909090909	22	6908	817,9748	CAMK2D,SLK
ko05206	MicroRNAs in cancer	0.0662313625517308	-2.71460117366757	297	3	0.136363636363636	22	6908	7431,960,4325	VIM,CD44,MMP16
hsa05206	MicroRNAs in cancer	0.0662313625517308	-2.71460117366757	297	3	0.136363636363636	22	6908	7431,960,4325	VIM,CD44,MMP16
hsa04310	Wnt signaling pathway	0.0732488886165842	-2.6138922036699	141	2	0.0909090909090909	22	6908	817,51384	CAMK2D,WNT16
ko04310	Wnt signaling pathway	0.0732488886165842	-2.6138922036699	141	2	0.0909090909090909	22	6908	817,51384	CAMK2D,WNT16
ko05216	Thyroid cancer	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	5468	PPARG
ko00030	Pentose phosphate pathway	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	5631	PRPS1
ko00760	Nicotinate and nicotinamide metabolism	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	4907	NT5E
hsa00030	Pentose phosphate pathway	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	5631	PRPS1
hsa00760	Nicotinate and nicotinamide metabolism	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	4907	NT5E
hsa05216	Thyroid cancer	0.0885261332998964	-2.42445747903396	29	1	0.0454545454545455	22	6908	5468	PPARG
hsa04151	PI3K-Akt signaling pathway	0.0949014626177661	-2.35491616128517	346	3	0.136363636363636	22	6908	3910,2254,3691	LAMA4,FGF9,ITGB4
ko04151	PI3K-Akt signaling pathway	0.0949014626177661	-2.35491616128517	346	3	0.136363636363636	22	6908	3910,2254,3691	LAMA4,FGF9,ITGB4
ko05143	African trypanosomiasis	0.103012491805677	-2.27290501843952	34	1	0.0454545454545455	22	6908	3910	LAMA4
hsa05143	African trypanosomiasis	0.103012491805677	-2.27290501843952	34	1	0.0454545454545455	22	6908	3910	LAMA4
hsa05202	Transcriptional misregulation in cancer	0.11004784024258	-2.20684009644005	179	2	0.0909090909090909	22	6908	51384,5468	WNT16,PPARG
ko05202	Transcriptional misregulation in cancer	0.11004784024258	-2.20684009644005	179	2	0.0909090909090909	22	6908	51384,5468	WNT16,PPARG
ko04024	cAMP signaling pathway	0.13107375670914	-2.03199508590791	199	2	0.0909090909090909	22	6908	817,5139	CAMK2D,PDE3A
ko05169	Epstein-Barr virus infection	0.13107375670914	-2.03199508590791	199	2	0.0909090909090909	22	6908	7431,960	VIM,CD44
hsa05169	Epstein-Barr virus infection	0.13107375670914	-2.03199508590791	199	2	0.0909090909090909	22	6908	7431,960	VIM,CD44
hsa04024	cAMP signaling pathway	0.13107375670914	-2.03199508590791	199	2	0.0909090909090909	22	6908	817,5139	CAMK2D,PDE3A
hsa04510	Focal adhesion	0.139741935572223	-1.96795787471415	207	2	0.0909090909090909	22	6908	3910,3691	LAMA4,ITGB4
ko04510	Focal adhesion	0.139741935572223	-1.96795787471415	207	2	0.0909090909090909	22	6908	3910,3691	LAMA4,ITGB4
ko04810	Regulation of actin cytoskeleton	0.147433258793119	-1.91437968836199	214	2	0.0909090909090909	22	6908	2254,3691	FGF9,ITGB4
hsa04810	Regulation of actin cytoskeleton	0.147433258793119	-1.91437968836199	214	2	0.0909090909090909	22	6908	2254,3691	FGF9,ITGB4
hsa04978	Mineral absorption	0.150639982935012	-1.89286250791649	51	1	0.0454545454545455	22	6908	30061	SLC40A1
ko04978	Mineral absorption	0.150639982935012	-1.89286250791649	51	1	0.0454545454545455	22	6908	30061	SLC40A1
ko05217	Basal cell carcinoma	0.161490345768206	-1.82330991663127	55	1	0.0454545454545455	22	6908	51384	WNT16
hsa05217	Basal cell carcinoma	0.161490345768206	-1.82330991663127	55	1	0.0454545454545455	22	6908	51384	WNT16
ko04721	Synaptic vesicle cycle	0.182795449241685	-1.69938751501111	63	1	0.0454545454545455	22	6908	23025	UNC13A
hsa04721	Synaptic vesicle cycle	0.182795449241685	-1.69938751501111	63	1	0.0454545454545455	22	6908	23025	UNC13A
hsa04924	Renin secretion	0.185421964964403	-1.68512115948914	64	1	0.0454545454545455	22	6908	5139	PDE3A
ko04924	Renin secretion	0.185421964964403	-1.68512115948914	64	1	0.0454545454545455	22	6908	5139	PDE3A
hsa05131	Shigellosis	0.185421964964403	-1.68512115948914	64	1	0.0454545454545455	22	6908	960	CD44
hsa05214	Glioma	0.18804042153296	-1.67109833110908	65	1	0.0454545454545455	22	6908	817	CAMK2D
ko05214	Glioma	0.18804042153296	-1.67109833110908	65	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04720	Long-term potentiation	0.1906508425059	-1.6573115735648	66	1	0.0454545454545455	22	6908	817	CAMK2D
ko04720	Long-term potentiation	0.1906508425059	-1.6573115735648	66	1	0.0454545454545455	22	6908	817	CAMK2D
hsa05031	Amphetamine addiction	0.193253251377062	-1.64375376693654	67	1	0.0454545454545455	22	6908	817	CAMK2D
ko05031	Amphetamine addiction	0.193253251377062	-1.64375376693654	67	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04622	RIG-I-like receptor signaling pathway	0.201012639240703	-1.6043874911055	70	1	0.0454545454545455	22	6908	10010	TANK
ko04622	RIG-I-like receptor signaling pathway	0.201012639240703	-1.6043874911055	70	1	0.0454545454545455	22	6908	10010	TANK
hsa05218	Melanoma	0.203583233265344	-1.59168034904583	71	1	0.0454545454545455	22	6908	2254	FGF9
ko05218	Melanoma	0.203583233265344	-1.59168034904583	71	1	0.0454545454545455	22	6908	2254	FGF9
hsa01230	Biosynthesis of amino acids	0.208700757501613	-1.56685383528596	73	1	0.0454545454545455	22	6908	5631	PRPS1
ko01230	Biosynthesis of amino acids	0.208700757501613	-1.56685383528596	73	1	0.0454545454545455	22	6908	5631	PRPS1
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.211247733847139	-1.55472374015321	74	1	0.0454545454545455	22	6908	3691	ITGB4
hsa04971	Gastric acid secretion	0.211247733847139	-1.55472374015321	74	1	0.0454545454545455	22	6908	817	CAMK2D
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.211247733847139	-1.55472374015321	74	1	0.0454545454545455	22	6908	3691	ITGB4
ko04971	Gastric acid secretion	0.211247733847139	-1.55472374015321	74	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04925	Aldosterone synthesis and secretion	0.22885870385347	-1.47465047959952	81	1	0.0454545454545455	22	6908	817	CAMK2D
ko04925	Aldosterone synthesis and secretion	0.22885870385347	-1.47465047959952	81	1	0.0454545454545455	22	6908	817	CAMK2D
ko05410	Hypertrophic cardiomyopathy (HCM)	0.233821062770206	-1.45319914516443	83	1	0.0454545454545455	22	6908	3691	ITGB4
hsa05410	Hypertrophic cardiomyopathy (HCM)	0.233821062770206	-1.45319914516443	83	1	0.0454545454545455	22	6908	3691	ITGB4
hsa04911	Insulin secretion	0.238752931080068	-1.4323260229215	85	1	0.0454545454545455	22	6908	817	CAMK2D
hsa05222	Small cell lung cancer	0.24120748707058	-1.42209777368807	86	1	0.0454545454545455	22	6908	3910	LAMA4
ko05222	Small cell lung cancer	0.24120748707058	-1.42209777368807	86	1	0.0454545454545455	22	6908	3910	LAMA4
hsa04012	ErbB signaling pathway	0.243654487260704	-1.4120040930319	87	1	0.0454545454545455	22	6908	817	CAMK2D
ko04640	Hematopoietic cell lineage	0.243654487260704	-1.4120040930319	87	1	0.0454545454545455	22	6908	960	CD44
ko04012	ErbB signaling pathway	0.243654487260704	-1.4120040930319	87	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04640	Hematopoietic cell lineage	0.243654487260704	-1.4120040930319	87	1	0.0454545454545455	22	6908	960	CD44
ko05414	Dilated cardiomyopathy	0.248525908790741	-1.3922081781529	89	1	0.0454545454545455	22	6908	3691	ITGB4
hsa05414	Dilated cardiomyopathy	0.248525908790741	-1.3922081781529	89	1	0.0454545454545455	22	6908	3691	ITGB4
ko04912	GnRH signaling pathway	0.253367372163701	-1.37291477959179	91	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04912	GnRH signaling pathway	0.253367372163701	-1.37291477959179	91	1	0.0454545454545455	22	6908	817	CAMK2D
ko04713	Circadian entrainment	0.262961125544236	-1.33574906934846	95	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04713	Circadian entrainment	0.262961125544236	-1.33574906934846	95	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04750	Inflammatory mediator regulation of TRP channels	0.270079098719144	-1.30904040466859	98	1	0.0454545454545455	22	6908	817	CAMK2D
ko04750	Inflammatory mediator regulation of TRP channels	0.270079098719144	-1.30904040466859	98	1	0.0454545454545455	22	6908	817	CAMK2D
ko04922	Glucagon signaling pathway	0.277131425676053	-1.28326342439141	101	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04922	Glucagon signaling pathway	0.277131425676053	-1.28326342439141	101	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04066	HIF-1 signaling pathway	0.281796791925496	-1.266569063807	103	1	0.0454545454545455	22	6908	817	CAMK2D
hsa00240	Pyrimidine metabolism	0.284118683264121	-1.25836322929899	104	1	0.0454545454545455	22	6908	4907	NT5E
ko00240	Pyrimidine metabolism	0.284118683264121	-1.25836322929899	104	1	0.0454545454545455	22	6908	4907	NT5E
hsa05146	Amoebiasis	0.291041443513673	-1.23428960437831	107	1	0.0454545454545455	22	6908	3910	LAMA4
ko05146	Amoebiasis	0.291041443513673	-1.23428960437831	107	1	0.0454545454545455	22	6908	3910	LAMA4
hsa04725	Cholinergic synapse	0.30017244108503	-1.20339816584549	111	1	0.0454545454545455	22	6908	817	CAMK2D
ko01200	Carbon metabolism	0.304695736284025	-1.18844158624878	113	1	0.0454545454545455	22	6908	5631	PRPS1
hsa01200	Carbon metabolism	0.304695736284025	-1.18844158624878	113	1	0.0454545454545455	22	6908	5631	PRPS1
hsa05145	Toxoplasmosis	0.31588220339968	-1.15238590894439	118	1	0.0454545454545455	22	6908	3910	LAMA4
ko05145	Toxoplasmosis	0.31588220339968	-1.15238590894439	118	1	0.0454545454545455	22	6908	3910	LAMA4
ko04722	Neurotrophin signaling pathway	0.320308510908354	-1.13847065104239	120	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04722	Neurotrophin signaling pathway	0.320308510908354	-1.13847065104239	120	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04152	AMPK signaling pathway	0.32689675077217	-1.11811090481752	123	1	0.0454545454545455	22	6908	5468	PPARG
ko04152	AMPK signaling pathway	0.32689675077217	-1.11811090481752	123	1	0.0454545454545455	22	6908	5468	PPARG
hsa04360	Axon guidance	0.335586299848386	-1.09187612808176	127	1	0.0454545454545455	22	6908	1948	EFNB2
ko04360	Axon guidance	0.335586299848386	-1.09187612808176	127	1	0.0454545454545455	22	6908	1948	EFNB2
ko04728	Dopaminergic synapse	0.339890816672453	-1.07913084037835	129	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04728	Dopaminergic synapse	0.339890816672453	-1.07913084037835	129	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04380	Osteoclast differentiation	0.344168705726139	-1.0666233182046	131	1	0.0454545454545455	22	6908	5468	PPARG
ko04380	Osteoclast differentiation	0.344168705726139	-1.0666233182046	131	1	0.0454545454545455	22	6908	5468	PPARG
hsa04550	Signaling pathways regulating pluripotency of stem cells	0.367228092553994	-1.00177211838547	142	1	0.0454545454545455	22	6908	51384	WNT16
ko04550	Signaling pathways regulating pluripotency of stem cells	0.367228092553994	-1.00177211838547	142	1	0.0454545454545455	22	6908	51384	WNT16
ko04261	Adrenergic signaling in cardiomyocytes	0.379477610217932	-0.968959681995124	148	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04261	Adrenergic signaling in cardiomyocytes	0.379477610217932	-0.968959681995124	148	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04390	Hippo signaling pathway	0.391500574616214	-0.937768295822563	154	1	0.0454545454545455	22	6908	51384	WNT16
ko04390	Hippo signaling pathway	0.391500574616214	-0.937768295822563	154	1	0.0454545454545455	22	6908	51384	WNT16
ko04921	Oxytocin signaling pathway	0.397428350109099	-0.922740612432831	157	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04921	Oxytocin signaling pathway	0.397428350109099	-0.922740612432831	157	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04022	cGMP-PKG signaling pathway	0.416792064592579	-0.875167827609588	167	1	0.0454545454545455	22	6908	5139	PDE3A
ko04022	cGMP-PKG signaling pathway	0.416792064592579	-0.875167827609588	167	1	0.0454545454545455	22	6908	5139	PDE3A
ko05152	Tuberculosis	0.435560936768466	-0.831120568784609	177	1	0.0454545454545455	22	6908	817	CAMK2D
hsa05152	Tuberculosis	0.435560936768466	-0.831120568784609	177	1	0.0454545454545455	22	6908	817	CAMK2D
ko04020	Calcium signaling pathway	0.439244872474748	-0.822698225347328	179	1	0.0454545454545455	22	6908	817	CAMK2D
hsa04020	Calcium signaling pathway	0.439244872474748	-0.822698225347328	179	1	0.0454545454545455	22	6908	817	CAMK2D
ko05016	Huntington's disease	0.453752395247186	-0.790203614635332	187	1	0.0454545454545455	22	6908	5468	PPARG
hsa05016	Huntington's disease	0.453752395247186	-0.790203614635332	187	1	0.0454545454545455	22	6908	5468	PPARG
hsa01130	Biosynthesis of antibiotics	0.493492790363556	-0.706247029407705	210	1	0.0454545454545455	22	6908	5631	PRPS1
hsa04015	Rap1 signaling pathway	0.4951564449789	-0.702881515884449	211	1	0.0454545454545455	22	6908	2254	FGF9
ko04015	Rap1 signaling pathway	0.4951564449789	-0.702881515884449	211	1	0.0454545454545455	22	6908	2254	FGF9
hsa04014	Ras signaling pathway	0.521075928412073	-0.651859511931531	227	1	0.0454545454545455	22	6908	2254	FGF9
hsa04010	MAPK signaling pathway	0.563407299641446	-0.573752467213705	255	1	0.0454545454545455	22	6908	2254	FGF9
ko04010	MAPK signaling pathway	0.563407299641446	-0.573752467213705	255	1	0.0454545454545455	22	6908	2254	FGF9
hsa04740	Olfactory transduction	0.734956921524069	-0.307943391658279	404	1	0.0454545454545455	22	6908	817	CAMK2D
ko04740	Olfactory transduction	0.734956921524069	-0.307943391658279	404	1	0.0454545454545455	22	6908	817	CAMK2D
hsa01100	Metabolic pathways	0.919312366920542	-0.0841293156623471	1214	2	0.0909090909090909	22	6908	5631,4907	PRPS1,NT5E
ko05231	Choline metabolism in cancer	0.999999999980337	-1.96630922701018e-11	101	0	0	22	6908
ko04723	Retrograde endocannabinoid signaling	0.999999999980337	-1.96630922701018e-11	101	0	0	22	6908
hsa04723	Retrograde endocannabinoid signaling	0.999999999980337	-1.96630922701018e-11	101	0	0	22	6908
hsa05231	Choline metabolism in cancer	0.999999999980337	-1.96630922701018e-11	101	0	0	22	6908
ko00232	Caffeine metabolism	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
hsa00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
hsa00524	Butirosin and neomycin biosynthesis	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
ko00524	Butirosin and neomycin biosynthesis	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
hsa00232	Caffeine metabolism	0.999999999981029	-1.89714547342105e-11	5	0	0	22	6908
hsa04110	Cell cycle	0.999999999981252	-1.87475188659881e-11	124	0	0	22	6908
ko04110	Cell cycle	0.999999999981252	-1.87475188659881e-11	124	0	0	22	6908
hsa00770	Pantothenate and CoA biosynthesis	0.999999999981452	-1.85483105961159e-11	18	0	0	22	6908
ko00770	Pantothenate and CoA biosynthesis	0.999999999981452	-1.85483105961159e-11	18	0	0	22	6908
hsa00511	Other glycan degradation	0.999999999981452	-1.85483105961159e-11	18	0	0	22	6908
ko00511	Other glycan degradation	0.999999999981452	-1.85483105961159e-11	18	0	0	22	6908
ko00740	Riboflavin metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
hsa00290	Valine, leucine and isoleucine biosynthesis	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
ko00471	D-Glutamine and D-glutamate metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
hsa00471	D-Glutamine and D-glutamate metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
hsa00740	Riboflavin metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
ko00290	Valine, leucine and isoleucine biosynthesis	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
hsa00730	Thiamine metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
ko00730	Thiamine metabolism	0.999999999982094	-1.79059019429755e-11	4	0	0	22	6908
ko05332	Graft-versus-host disease	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
hsa04975	Fat digestion and absorption	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
hsa05332	Graft-versus-host disease	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
ko05219	Bladder cancer	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
ko04975	Fat digestion and absorption	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
hsa05219	Bladder cancer	0.999999999982383	-1.76174719816661e-11	41	0	0	22	6908
hsa04940	Type I diabetes mellitus	0.999999999983897	-1.61031000653947e-11	43	0	0	22	6908
ko04940	Type I diabetes mellitus	0.999999999983897	-1.61031000653947e-11	43	0	0	22	6908
ko04915	Estrogen signaling pathway	0.999999999983951	-1.60495286001624e-11	99	0	0	22	6908
hsa04915	Estrogen signaling pathway	0.999999999983951	-1.60495286001624e-11	99	0	0	22	6908
hsa00300	Lysine biosynthesis	0.999999999984396	-1.56037519822525e-11	2	0	0	22	6908
ko00300	Lysine biosynthesis	0.999999999984396	-1.56037519822525e-11	2	0	0	22	6908
ko04724	Glutamatergic synapse	0.999999999985019	-1.49813873593602e-11	114	0	0	22	6908
hsa04724	Glutamatergic synapse	0.999999999985019	-1.49813873593602e-11	114	0	0	22	6908
hsa04060	Cytokine-cytokine receptor interaction	0.999999999986311	-1.36894744487745e-11	265	0	0	22	6908
ko04060	Cytokine-cytokine receptor interaction	0.999999999986311	-1.36894744487745e-11	265	0	0	22	6908
ko04973	Carbohydrate digestion and absorption	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
ko00565	Ether lipid metabolism	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
hsa00565	Ether lipid metabolism	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
hsa04973	Carbohydrate digestion and absorption	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
hsa03022	Basal transcription factors	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
ko03022	Basal transcription factors	0.999999999987212	-1.27877804877533e-11	45	0	0	22	6908
hsa04150	mTOR signaling pathway	0.999999999987837	-1.21631479837568e-11	60	0	0	22	6908
ko04150	mTOR signaling pathway	0.999999999987837	-1.21631479837568e-11	60	0	0	22	6908
hsa04730	Long-term depression	0.999999999987837	-1.21631479837568e-11	60	0	0	22	6908
ko04730	Long-term depression	0.999999999987837	-1.21631479837568e-11	60	0	0	22	6908
hsa04070	Phosphatidylinositol signaling system	0.999999999987884	-1.2116336568014e-11	98	0	0	22	6908
ko04070	Phosphatidylinositol signaling system	0.999999999987884	-1.2116336568014e-11	98	0	0	22	6908
hsa03450	Non-homologous end-joining	0.999999999988108	-1.18921322271155e-11	13	0	0	22	6908
hsa00061	Fatty acid biosynthesis	0.999999999988108	-1.18921322271155e-11	13	0	0	22	6908
ko03450	Non-homologous end-joining	0.999999999988108	-1.18921322271155e-11	13	0	0	22	6908
ko00061	Fatty acid biosynthesis	0.999999999988108	-1.18921322271155e-11	13	0	0	22	6908
hsa04727	GABAergic synapse	0.999999999988225	-1.17748279093998e-11	88	0	0	22	6908
ko04727	GABAergic synapse	0.999999999988225	-1.17748279093998e-11	88	0	0	22	6908
hsa04540	Gap junction	0.999999999988225	-1.17748279093998e-11	88	0	0	22	6908
ko04540	Gap junction	0.999999999988225	-1.17748279093998e-11	88	0	0	22	6908
ko00330	Arginine and proline metabolism	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
hsa05144	Malaria	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
ko00510	N-Glycan biosynthesis	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
hsa00330	Arginine and proline metabolism	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
hsa00510	N-Glycan biosynthesis	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
ko05144	Malaria	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
hsa05030	Cocaine addiction	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
ko05030	Cocaine addiction	0.999999999988303	-1.16964780329729e-11	49	0	0	22	6908
ko04610	Complement and coagulation cascades	0.999999999988672	-1.13280193058931e-11	69	0	0	22	6908
hsa04610	Complement and coagulation cascades	0.999999999988672	-1.13280193058931e-11	69	0	0	22	6908
ko00860	Porphyrin and chlorophyll metabolism	0.999999999988768	-1.12320225877144e-11	42	0	0	22	6908
hsa00860	Porphyrin and chlorophyll metabolism	0.999999999988768	-1.12320225877144e-11	42	0	0	22	6908
ko03040	Spliceosome	0.999999999989171	-1.08285627945162e-11	132	0	0	22	6908
hsa03040	Spliceosome	0.999999999989171	-1.08285627945162e-11	132	0	0	22	6908
hsa00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
ko00592	alpha-Linolenic acid metabolism	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
hsa00592	alpha-Linolenic acid metabolism	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
hsa00062	Fatty acid elongation	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
ko00062	Fatty acid elongation	0.999999999989295	-1.07046361205218e-11	25	0	0	22	6908
ko04620	Toll-like receptor signaling pathway	0.999999999989566	-1.04336215037743e-11	106	0	0	22	6908
hsa04620	Toll-like receptor signaling pathway	0.999999999989566	-1.04336215037743e-11	106	0	0	22	6908
ko00140	Steroid hormone biosynthesis	0.999999999989637	-1.03625940590016e-11	58	0	0	22	6908
hsa05416	Viral myocarditis	0.999999999989637	-1.03625940590016e-11	58	0	0	22	6908
hsa00140	Steroid hormone biosynthesis	0.999999999989637	-1.03625940590016e-11	58	0	0	22	6908
hsa00591	Linoleic acid metabolism	0.999999999989873	-1.01273675619721e-11	29	0	0	22	6908
hsa03440	Homologous recombination	0.999999999989873	-1.01273675619721e-11	29	0	0	22	6908
ko03440	Homologous recombination	0.999999999989873	-1.01273675619721e-11	29	0	0	22	6908
ko00591	Linoleic acid metabolism	0.999999999989873	-1.01273675619721e-11	29	0	0	22	6908
ko04260	Cardiac muscle contraction	0.999999999990378	-9.62182954071777e-12	74	0	0	22	6908
hsa04260	Cardiac muscle contraction	0.999999999990378	-9.62182954071777e-12	74	0	0	22	6908
hsa00980	Metabolism of xenobiotics by cytochrome P450	0.999999999990378	-9.62182954071777e-12	74	0	0	22	6908
ko00980	Metabolism of xenobiotics by cytochrome P450	0.999999999990378	-9.62182954071777e-12	74	0	0	22	6908
ko03410	Base excision repair	0.999999999990388	-9.61171210537793e-12	33	0	0	22	6908
hsa03410	Base excision repair	0.999999999990388	-9.61171210537793e-12	33	0	0	22	6908
hsa05140	Leishmaniasis	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
ko05140	Leishmaniasis	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
hsa04662	B cell receptor signaling pathway	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
hsa04917	Prolactin signaling pathway	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
ko04917	Prolactin signaling pathway	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
ko04662	B cell receptor signaling pathway	0.999999999990422	-9.57811662093734e-12	72	0	0	22	6908
ko00900	Terpenoid backbone biosynthesis	0.999999999990507	-9.49285914534529e-12	22	0	0	22	6908
hsa00900	Terpenoid backbone biosynthesis	0.999999999990507	-9.49285914534529e-12	22	0	0	22	6908
ko05130	Pathogenic Escherichia coli infection	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
hsa05134	Legionellosis	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
hsa05150	Staphylococcus aureus infection	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
ko05150	Staphylococcus aureus infection	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
hsa05130	Pathogenic Escherichia coli infection	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
ko05134	Legionellosis	0.999999999990654	-9.34602206709399e-12	55	0	0	22	6908
hsa05014	Amyotrophic lateral sclerosis (ALS)	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
ko04742	Taste transduction	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
hsa00480	Glutathione metabolism	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
ko05014	Amyotrophic lateral sclerosis (ALS)	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
hsa04742	Taste transduction	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
ko00480	Glutathione metabolism	0.999999999991093	-8.90675787767749e-12	51	0	0	22	6908
ko04120	Ubiquitin mediated proteolysis	0.999999999991197	-8.80337546863608e-12	137	0	0	22	6908
hsa04120	Ubiquitin mediated proteolysis	0.999999999991197	-8.80337546863608e-12	137	0	0	22	6908
hsa00830	Retinol metabolism	0.999999999991349	-8.65100866934626e-12	65	0	0	22	6908
ko05321	Inflammatory bowel disease (IBD)	0.999999999991349	-8.65100866934626e-12	65	0	0	22	6908
ko00830	Retinol metabolism	0.999999999991349	-8.65100866934626e-12	65	0	0	22	6908
hsa05321	Inflammatory bowel disease (IBD)	0.999999999991349	-8.65100866934626e-12	65	0	0	22	6908
hsa00310	Lysine degradation	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
hsa05213	Endometrial cancer	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
hsa05320	Autoimmune thyroid disease	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
ko00310	Lysine degradation	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
ko05320	Autoimmune thyroid disease	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
ko05213	Endometrial cancer	0.999999999991705	-8.29546754398157e-12	52	0	0	22	6908
hsa05012	Parkinson's disease	0.999999999991758	-8.24154136078388e-12	129	0	0	22	6908
ko00561	Glycerolipid metabolism	0.999999999992022	-7.97817301658548e-12	59	0	0	22	6908
hsa00561	Glycerolipid metabolism	0.999999999992022	-7.97817301658548e-12	59	0	0	22	6908
ko04062	Chemokine signaling pathway	0.999999999992044	-7.95602771109502e-12	187	0	0	22	6908
hsa04062	Chemokine signaling pathway	0.999999999992044	-7.95602771109502e-12	187	0	0	22	6908
ko05033	Nicotine addiction	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
ko00380	Tryptophan metabolism	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
hsa05033	Nicotine addiction	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
ko00620	Pyruvate metabolism	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
hsa00620	Pyruvate metabolism	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
hsa00380	Tryptophan metabolism	0.999999999992053	-7.94724091484155e-12	40	0	0	22	6908
ko00350	Tyrosine metabolism	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
ko05020	Prion diseases	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
hsa00350	Tyrosine metabolism	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
hsa00250	Alanine, aspartate and glutamate metabolism	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
hsa05020	Prion diseases	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
ko00250	Alanine, aspartate and glutamate metabolism	0.999999999992054	-7.94613879798586e-12	35	0	0	22	6908
hsa02010	ABC transporters	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
ko00071	Fatty acid degradation	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
ko02010	ABC transporters	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
hsa03050	Proteasome	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
ko04962	Vasopressin-regulated water reabsorption	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
hsa00071	Fatty acid degradation	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
hsa00970	Aminoacyl-tRNA biosynthesis	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
hsa04962	Vasopressin-regulated water reabsorption	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
ko03050	Proteasome	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
ko00970	Aminoacyl-tRNA biosynthesis	0.999999999992446	-7.553647460021e-12	44	0	0	22	6908
hsa04913	Ovarian steroidogenesis	0.999999999992458	-7.54155255818449e-12	50	0	0	22	6908
ko04913	Ovarian steroidogenesis	0.999999999992458	-7.54155255818449e-12	50	0	0	22	6908
hsa04611	Platelet activation	0.99999999999279	-7.21020317785726e-12	130	0	0	22	6908
ko04140	Regulation of autophagy	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
ko04960	Aldosterone-regulated sodium reabsorption	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
hsa04140	Regulation of autophagy	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
ko00260	Glycine, serine and threonine metabolism	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
hsa00260	Glycine, serine and threonine metabolism	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
hsa04960	Aldosterone-regulated sodium reabsorption	0.999999999992849	-7.15125459331714e-12	39	0	0	22	6908
hsa00190	Oxidative phosphorylation	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
hsa04270	Vascular smooth muscle contraction	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
ko04270	Vascular smooth muscle contraction	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
ko04071	Sphingolipid signaling pathway	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
hsa04071	Sphingolipid signaling pathway	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
ko00190	Oxidative phosphorylation	0.999999999993	-6.99973702566835e-12	120	0	0	22	6908
hsa04122	Sulfur relay system	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
ko00920	Sulfur metabolism	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
hsa00072	Synthesis and degradation of ketone bodies	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
ko04122	Sulfur relay system	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
hsa00920	Sulfur metabolism	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
ko00072	Synthesis and degradation of ketone bodies	0.999999999993086	-6.91395499683187e-12	10	0	0	22	6908
ko04670	Leukocyte transendothelial migration	0.999999999993606	-6.39401924413419e-12	118	0	0	22	6908
hsa04670	Leukocyte transendothelial migration	0.999999999993606	-6.39401924413419e-12	118	0	0	22	6908
hsa04919	Thyroid hormone signaling pathway	0.999999999993606	-6.39401924413419e-12	118	0	0	22	6908
ko00051	Fructose and mannose metabolism	0.999999999993902	-6.09785877117586e-12	32	0	0	22	6908
hsa00051	Fructose and mannose metabolism	0.999999999993902	-6.09785877117586e-12	32	0	0	22	6908
hsa00472	D-Arginine and D-ornithine metabolism	0.999999999994083	-5.9165779914272e-12	1	0	0	22	6908
ko00472	D-Arginine and D-ornithine metabolism	0.999999999994083	-5.9165779914272e-12	1	0	0	22	6908
hsa04210	Apoptosis	0.999999999994101	-5.89885005255805e-12	85	0	0	22	6908
ko04210	Apoptosis	0.999999999994101	-5.89885005255805e-12	85	0	0	22	6908
ko05132	Salmonella infection	0.999999999994101	-5.89885005255805e-12	85	0	0	22	6908
hsa05132	Salmonella infection	0.999999999994101	-5.89885005255805e-12	85	0	0	22	6908
ko05160	Hepatitis C	0.999999999994274	-5.72639805454275e-12	133	0	0	22	6908
hsa03010	Ribosome	0.999999999994274	-5.72639805454275e-12	133	0	0	22	6908
ko03010	Ribosome	0.999999999994274	-5.72639805454275e-12	133	0	0	22	6908
hsa05160	Hepatitis C	0.999999999994274	-5.72639805454275e-12	133	0	0	22	6908
ko04630	Jak-STAT signaling pathway	0.999999999994401	-5.59931424617242e-12	158	0	0	22	6908
hsa04630	Jak-STAT signaling pathway	0.999999999994401	-5.59931424617242e-12	158	0	0	22	6908
hsa04976	Bile secretion	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
ko04976	Bile secretion	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
hsa00562	Inositol phosphate metabolism	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
ko00562	Inositol phosphate metabolism	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
hsa04918	Thyroid hormone synthesis	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
ko04918	Thyroid hormone synthesis	0.999999999994482	-5.51852518301079e-12	71	0	0	22	6908
hsa05223	Non-small cell lung cancer	0.99999999999451	-5.49018691658135e-12	56	0	0	22	6908
ko00500	Starch and sucrose metabolism	0.99999999999451	-5.49018691658135e-12	56	0	0	22	6908
hsa00500	Starch and sucrose metabolism	0.99999999999451	-5.49018691658135e-12	56	0	0	22	6908
ko05223	Non-small cell lung cancer	0.99999999999451	-5.49018691658135e-12	56	0	0	22	6908
hsa04923	Regulation of lipolysis in adipocytes	0.99999999999451	-5.49018691658135e-12	56	0	0	22	6908
hsa00910	Nitrogen metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
hsa00450	Selenocompound metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
ko00120	Primary bile acid biosynthesis	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
ko01210	2-Oxocarboxylic acid metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
hsa00360	Phenylalanine metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
hsa01210	2-Oxocarboxylic acid metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
ko00360	Phenylalanine metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
ko00910	Nitrogen metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
ko00450	Selenocompound metabolism	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
hsa00120	Primary bile acid biosynthesis	0.999999999994532	-5.46815052375348e-12	17	0	0	22	6908
hsa04530	Tight junction	0.99999999999498	-5.01971745716567e-12	138	0	0	22	6908
ko04530	Tight junction	0.99999999999498	-5.01971745716567e-12	138	0	0	22	6908
ko05133	Pertussis	0.999999999995033	-4.9672111023814e-12	75	0	0	22	6908
hsa05133	Pertussis	0.999999999995033	-4.9672111023814e-12	75	0	0	22	6908
ko00514	Other types of O-glycan biosynthesis	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa04710	Circadian rhythm	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
ko04710	Circadian rhythm	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
ko00512	Mucin type O-Glycan biosynthesis	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa00512	Mucin type O-Glycan biosynthesis	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa00514	Other types of O-glycan biosynthesis	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
ko00410	beta-Alanine metabolism	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
ko03020	RNA polymerase	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa03020	RNA polymerase	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa00410	beta-Alanine metabolism	0.999999999995171	-4.82863490747821e-12	31	0	0	22	6908
hsa03008	Ribosome biogenesis in eukaryotes	0.999999999995293	-4.7070809900023e-12	78	0	0	22	6908
hsa05100	Bacterial invasion of epithelial cells	0.999999999995293	-4.7070809900023e-12	78	0	0	22	6908
ko03008	Ribosome biogenesis in eukaryotes	0.999999999995293	-4.7070809900023e-12	78	0	0	22	6908
ko05100	Bacterial invasion of epithelial cells	0.999999999995293	-4.7070809900023e-12	78	0	0	22	6908
ko04130	SNARE interactions in vesicular transport	0.999999999995414	-4.58616522370735e-12	34	0	0	22	6908
hsa04130	SNARE interactions in vesicular transport	0.999999999995414	-4.58616522370735e-12	34	0	0	22	6908
ko04370	VEGF signaling pathway	0.999999999995521	-4.47888031103754e-12	61	0	0	22	6908
hsa04370	VEGF signaling pathway	0.999999999995521	-4.47888031103754e-12	61	0	0	22	6908
hsa00983	Drug metabolism - other enzymes	0.999999999995776	-4.22400741405845e-12	46	0	0	22	6908
ko00983	Drug metabolism - other enzymes	0.999999999995776	-4.22400741405845e-12	46	0	0	22	6908
ko04744	Phototransduction	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
hsa00630	Glyoxylate and dicarboxylate metabolism	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
ko00640	Propanoate metabolism	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
hsa04744	Phototransduction	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
hsa00640	Propanoate metabolism	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
ko00630	Glyoxylate and dicarboxylate metabolism	0.999999999996036	-3.96399125804008e-12	28	0	0	22	6908
hsa03030	DNA replication	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
ko03030	DNA replication	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
hsa05340	Primary immunodeficiency	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
ko00040	Pentose and glucuronate interconversions	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
hsa00040	Pentose and glucuronate interconversions	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
ko05340	Primary immunodeficiency	0.999999999996246	-3.75395823791829e-12	36	0	0	22	6908
ko00785	Lipoic acid metabolism	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
hsa00780	Biotin metabolism	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
ko01220	Degradation of aromatic compounds	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
hsa01220	Degradation of aromatic compounds	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
hsa00785	Lipoic acid metabolism	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
ko00780	Biotin metabolism	0.999999999996254	-3.74635041978319e-12	3	0	0	22	6908
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999996473	-3.52711158847727e-12	24	0	0	22	6908
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999996473	-3.52711158847727e-12	24	0	0	22	6908
hsa04977	Vitamin digestion and absorption	0.999999999996473	-3.52711158847727e-12	24	0	0	22	6908
ko04977	Vitamin digestion and absorption	0.999999999996473	-3.52711158847727e-12	24	0	0	22	6908
hsa00460	Cyanoamino acid metabolism	0.999999999996608	-3.39196090334256e-12	7	0	0	22	6908
ko00460	Cyanoamino acid metabolism	0.999999999996608	-3.39196090334256e-12	7	0	0	22	6908
hsa05164	Influenza A	0.999999999996673	-3.32736898616014e-12	174	0	0	22	6908
ko05164	Influenza A	0.999999999996673	-3.32736898616014e-12	174	0	0	22	6908
ko00052	Galactose metabolism	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
hsa05310	Asthma	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
ko00020	Citrate cycle (TCA cycle)	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
hsa00052	Galactose metabolism	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
hsa00020	Citrate cycle (TCA cycle)	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
ko05310	Asthma	0.999999999996805	-3.19472326661936e-12	30	0	0	22	6908
hsa00531	Glycosaminoglycan degradation	0.999999999996853	-3.14679523488422e-12	19	0	0	22	6908
ko00531	Glycosaminoglycan degradation	0.999999999996853	-3.14679523488422e-12	19	0	0	22	6908
ko00520	Amino sugar and nucleotide sugar metabolism	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
ko04330	Notch signaling pathway	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
hsa01212	Fatty acid metabolism	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
hsa00520	Amino sugar and nucleotide sugar metabolism	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
ko01212	Fatty acid metabolism	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
ko04930	Type II diabetes mellitus	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
hsa04330	Notch signaling pathway	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
hsa04930	Type II diabetes mellitus	0.999999999996905	-3.09454436235142e-12	48	0	0	22	6908
hsa03460	Fanconi anemia pathway	0.999999999997009	-2.99070359894667e-12	53	0	0	22	6908
ko05110	Vibrio cholerae infection	0.999999999997009	-2.99070359894667e-12	53	0	0	22	6908
hsa05110	Vibrio cholerae infection	0.999999999997009	-2.99070359894667e-12	53	0	0	22	6908
ko03460	Fanconi anemia pathway	0.999999999997009	-2.99070359894667e-12	53	0	0	22	6908
hsa05010	Alzheimer's disease	0.999999999997364	-2.63633620295559e-12	162	0	0	22	6908
ko05010	Alzheimer's disease	0.999999999997364	-2.63633620295559e-12	162	0	0	22	6908
ko04668	TNF signaling pathway	0.999999999997475	-2.5245793038196e-12	110	0	0	22	6908
hsa04668	TNF signaling pathway	0.999999999997475	-2.5245793038196e-12	110	0	0	22	6908
ko05210	Colorectal cancer	0.999999999997736	-2.26387647441428e-12	62	0	0	22	6908
hsa00590	Arachidonic acid metabolism	0.999999999997736	-2.26387647441428e-12	62	0	0	22	6908
hsa05210	Colorectal cancer	0.999999999997736	-2.26387647441428e-12	62	0	0	22	6908
ko00590	Arachidonic acid metabolism	0.999999999997736	-2.26387647441428e-12	62	0	0	22	6908
ko04660	T cell receptor signaling pathway	0.999999999997799	-2.20076188081404e-12	104	0	0	22	6908
hsa05142	Chagas disease (American trypanosomiasis)	0.999999999997799	-2.20076188081404e-12	104	0	0	22	6908
ko05142	Chagas disease (American trypanosomiasis)	0.999999999997799	-2.20076188081404e-12	104	0	0	22	6908
hsa04660	T cell receptor signaling pathway	0.999999999997799	-2.20076188081404e-12	104	0	0	22	6908
ko00790	Folate biosynthesis	0.999999999998204	-1.79619122569514e-12	14	0	0	22	6908
hsa00790	Folate biosynthesis	0.999999999998204	-1.79619122569514e-12	14	0	0	22	6908
hsa00603	Glycosphingolipid biosynthesis - globo series	0.999999999998204	-1.79619122569514e-12	14	0	0	22	6908
ko00603	Glycosphingolipid biosynthesis - globo series	0.999999999998204	-1.79619122569514e-12	14	0	0	22	6908
hsa04141	Protein processing in endoplasmic reticulum	0.999999999998486	-1.5142549904074e-12	168	0	0	22	6908
ko04141	Protein processing in endoplasmic reticulum	0.999999999998486	-1.5142549904074e-12	168	0	0	22	6908
hsa04910	Insulin signaling pathway	0.999999999998553	-1.4472800882333e-12	139	0	0	22	6908
ko04910	Insulin signaling pathway	0.999999999998553	-1.4472800882333e-12	139	0	0	22	6908
hsa00564	Glycerophospholipid metabolism	0.999999999999023	-9.77010817389854e-13	95	0	0	22	6908
ko04972	Pancreatic secretion	0.999999999999023	-9.77010817389854e-13	95	0	0	22	6908
hsa04972	Pancreatic secretion	0.999999999999023	-9.77010817389854e-13	95	0	0	22	6908
ko00564	Glycerophospholipid metabolism	0.999999999999023	-9.77010817389854e-13	95	0	0	22	6908
hsa04621	NOD-like receptor signaling pathway	0.999999999999096	-9.0438025343364e-13	57	0	0	22	6908
hsa05221	Acute myeloid leukemia	0.999999999999096	-9.0438025343364e-13	57	0	0	22	6908
ko05221	Acute myeloid leukemia	0.999999999999096	-9.0438025343364e-13	57	0	0	22	6908
ko04621	NOD-like receptor signaling pathway	0.999999999999096	-9.0438025343364e-13	57	0	0	22	6908
ko04514	Cell adhesion molecules (CAMs)	0.999999999999335	-6.65480444503296e-13	142	0	0	22	6908
hsa04514	Cell adhesion molecules (CAMs)	0.999999999999335	-6.65480444503296e-13	142	0	0	22	6908
ko00010	Glycolysis / Gluconeogenesis	0.999999999999414	-5.85541368601725e-13	67	0	0	22	6908
hsa00010	Glycolysis / Gluconeogenesis	0.999999999999414	-5.85541368601725e-13	67	0	0	22	6908
ko05230	Central carbon metabolism in cancer	0.999999999999414	-5.85541368601725e-13	67	0	0	22	6908
hsa05230	Central carbon metabolism in cancer	0.999999999999414	-5.85541368601725e-13	67	0	0	22	6908
hsa00340	Histidine metabolism	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa04964	Proximal tubule bicarbonate reclamation	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa03060	Protein export	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko03430	Mismatch repair	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko03060	Protein export	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko01040	Biosynthesis of unsaturated fatty acids	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko04964	Proximal tubule bicarbonate reclamation	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa04614	Renin-angiotensin system	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko04614	Renin-angiotensin system	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa01040	Biosynthesis of unsaturated fatty acids	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa03430	Mismatch repair	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
ko00340	Histidine metabolism	0.999999999999916	-8.44656841613352e-14	23	0	0	22	6908
hsa00270	Cysteine and methionine metabolism	0.999999999999937	-6.32221036041446e-14	37	0	0	22	6908
ko00270	Cysteine and methionine metabolism	0.999999999999937	-6.32221036041446e-14	37	0	0	22	6908
hsa05330	Allograft rejection	0.999999999999937	-6.32221036041446e-14	37	0	0	22	6908
ko05330	Allograft rejection	0.999999999999937	-6.32221036041446e-14	37	0	0	22	6908
hsa04914	Progesterone-mediated oocyte maturation	1.00000000000008	7.61443175830019e-14	87	0	0	22	6908
ko04914	Progesterone-mediated oocyte maturation	1.00000000000008	7.61443175830019e-14	87	0	0	22	6908
ko04080	Neuroactive ligand-receptor interaction	1.00000000000036	3.576919175553e-13	276	0	0	22	6908
hsa04080	Neuroactive ligand-receptor interaction	1.00000000000036	3.576919175553e-13	276	0	0	22	6908
ko04666	Fc gamma R-mediated phagocytosis	1.00000000000036	3.59121631639076e-13	92	0	0	22	6908
hsa04666	Fc gamma R-mediated phagocytosis	1.00000000000036	3.59121631639076e-13	92	0	0	22	6908
ko03015	mRNA surveillance pathway	1.00000000000048	4.84156378048701e-13	91	0	0	22	6908
hsa04064	NF-kappa B signaling pathway	1.00000000000048	4.84156378048701e-13	91	0	0	22	6908
hsa03015	mRNA surveillance pathway	1.00000000000048	4.84156378048701e-13	91	0	0	22	6908
hsa04931	Insulin resistance	1.00000000000054	5.41393659272093e-13	111	0	0	22	6908
hsa04664	Fc epsilon RI signaling pathway	1.0000000000006	6.02171281720858e-13	70	0	0	22	6908
ko04920	Adipocytokine signaling pathway	1.0000000000006	6.02171281720858e-13	70	0	0	22	6908
ko04664	Fc epsilon RI signaling pathway	1.0000000000006	6.02171281720858e-13	70	0	0	22	6908
hsa04920	Adipocytokine signaling pathway	1.0000000000006	6.02171281720858e-13	70	0	0	22	6908
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.0000000000007	7.01476688465479e-13	15	0	0	22	6908
hsa00604	Glycosphingolipid biosynthesis - ganglio series	1.0000000000007	7.01476688465479e-13	15	0	0	22	6908
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.0000000000007	7.01476688465479e-13	15	0	0	22	6908
ko00604	Glycosphingolipid biosynthesis - ganglio series	1.0000000000007	7.01476688465479e-13	15	0	0	22	6908
hsa04726	Serotonergic synapse	1.00000000000071	7.06548193995389e-13	112	0	0	22	6908
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000073	7.34365999337121e-13	26	0	0	22	6908
hsa04950	Maturity onset diabetes of the young	1.00000000000073	7.34365999337121e-13	26	0	0	22	6908
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000073	7.34365999337121e-13	26	0	0	22	6908
ko04950	Maturity onset diabetes of the young	1.00000000000073	7.34365999337121e-13	26	0	0	22	6908
hsa04146	Peroxisome	1.000000000001	9.97064734663286e-13	83	0	0	22	6908
ko04146	Peroxisome	1.000000000001	9.97064734663286e-13	83	0	0	22	6908
ko05211	Renal cell carcinoma	1.00000000000119	1.19266464026016e-12	66	0	0	22	6908
ko05212	Pancreatic cancer	1.00000000000119	1.19266464026016e-12	66	0	0	22	6908
hsa05212	Pancreatic cancer	1.00000000000119	1.19266464026016e-12	66	0	0	22	6908
hsa05211	Renal cell carcinoma	1.00000000000119	1.19266464026016e-12	66	0	0	22	6908
ko04145	Phagosome	1.00000000000145	1.45219802194722e-12	152	0	0	22	6908
hsa04145	Phagosome	1.00000000000145	1.45219802194722e-12	152	0	0	22	6908
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
hsa04115	p53 signaling pathway	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
ko00982	Drug metabolism - cytochrome P450	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
hsa00982	Drug metabolism - cytochrome P450	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
ko04115	p53 signaling pathway	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
ko05120	Epithelial cell signaling in Helicobacter pylori infection	1.00000000000148	1.47554433922295e-12	68	0	0	22	6908
hsa00280	Valine, leucine and isoleucine degradation	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko04672	Intestinal immune network for IgA production	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko04961	Endocrine and other factor-regulated calcium reabsorption	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
hsa04672	Intestinal immune network for IgA production	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko00600	Sphingolipid metabolism	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
hsa03420	Nucleotide excision repair	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko00280	Valine, leucine and isoleucine degradation	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
hsa00600	Sphingolipid metabolism	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko03420	Nucleotide excision repair	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
hsa04961	Endocrine and other factor-regulated calcium reabsorption	1.00000000000151	1.51405290513919e-12	47	0	0	22	6908
ko04144	Endocytosis	1.00000000000191	1.91449376709786e-12	258	0	0	22	6908
hsa04144	Endocytosis	1.00000000000191	1.91449376709786e-12	258	0	0	22	6908
hsa05322	Systemic lupus erythematosus	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
ko05162	Measles	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
hsa05162	Measles	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
hsa04650	Natural killer cell mediated cytotoxicity	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
hsa04068	FoxO signaling pathway	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
ko04650	Natural killer cell mediated cytotoxicity	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
ko05322	Systemic lupus erythematosus	1.00000000000204	2.04474071750293e-12	134	0	0	22	6908
ko04350	TGF-beta signaling pathway	1.00000000000211	2.10970913431721e-12	84	0	0	22	6908
hsa04350	TGF-beta signaling pathway	1.00000000000211	2.10970913431721e-12	84	0	0	22	6908
ko05168	Herpes simplex infection	1.00000000000232	2.31908415172729e-12	184	0	0	22	6908
hsa05168	Herpes simplex infection	1.00000000000232	2.31908415172729e-12	184	0	0	22	6908
ko04970	Salivary secretion	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
hsa05323	Rheumatoid arthritis	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
hsa04974	Protein digestion and absorption	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
ko04974	Protein digestion and absorption	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
ko05323	Rheumatoid arthritis	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
hsa05215	Prostate cancer	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
ko05215	Prostate cancer	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
hsa04970	Salivary secretion	1.00000000000281	2.807751896816e-12	89	0	0	22	6908
hsa04612	Antigen processing and presentation	1.00000000000322	3.21790489528164e-12	77	0	0	22	6908
ko03018	RNA degradation	1.00000000000322	3.21790489528164e-12	77	0	0	22	6908
ko04612	Antigen processing and presentation	1.00000000000322	3.21790489528164e-12	77	0	0	22	6908
hsa03018	RNA degradation	1.00000000000322	3.21790489528164e-12	77	0	0	22	6908
ko05034	Alcoholism	1.00000000000332	3.31762264042432e-12	179	0	0	22	6908
hsa05034	Alcoholism	1.00000000000332	3.31762264042432e-12	179	0	0	22	6908
hsa00670	One carbon pool by folate	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
hsa00100	Steroid biosynthesis	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
ko00220	Arginine biosynthesis	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
hsa00220	Arginine biosynthesis	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
ko00670	One carbon pool by folate	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
ko00100	Steroid biosynthesis	1.00000000000335	3.34650894849677e-12	20	0	0	22	6908
hsa05204	Chemical carcinogenesis	1.00000000000361	3.60857679265005e-12	81	0	0	22	6908
ko05204	Chemical carcinogenesis	1.00000000000361	3.60857679265005e-12	81	0	0	22	6908
hsa05203	Viral carcinogenesis	1.00000000000392	3.9241662965829e-12	205	0	0	22	6908
ko05203	Viral carcinogenesis	1.00000000000392	3.9241662965829e-12	205	0	0	22	6908
hsa00750	Vitamin B6 metabolism	1.00000000000395	3.95188507278124e-12	6	0	0	22	6908
ko00750	Vitamin B6 metabolism	1.00000000000395	3.95188507278124e-12	6	0	0	22	6908
hsa05161	Hepatitis B	1.00000000000479	4.79367104110556e-12	146	0	0	22	6908
ko04520	Adherens junction	1.0000000000048	4.80043518013127e-12	73	0	0	22	6908
hsa04520	Adherens junction	1.0000000000048	4.80043518013127e-12	73	0	0	22	6908
hsa05220	Chronic myeloid leukemia	1.0000000000048	4.80043518013127e-12	73	0	0	22	6908
ko05220	Chronic myeloid leukemia	1.0000000000048	4.80043518013127e-12	73	0	0	22	6908
ko03013	RNA transport	1.00000000000492	4.92266602095446e-12	166	0	0	22	6908
hsa03013	RNA transport	1.00000000000492	4.92266602095446e-12	166	0	0	22	6908
hsa04142	Lysosome	1.00000000000559	5.59261800228057e-12	123	0	0	22	6908
ko04142	Lysosome	1.00000000000559	5.59261800228057e-12	123	0	0	22	6908
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.0000000000071	7.10502042278571e-12	11	0	0	22	6908
hsa00430	Taurine and hypotaurine metabolism	1.0000000000071	7.10502042278571e-12	11	0	0	22	6908
hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.0000000000071	7.10502042278571e-12	11	0	0	22	6908
ko00430	Taurine and hypotaurine metabolism	1.0000000000071	7.10502042278571e-12	11	0	0	22	6908
hsa04623	Cytosolic DNA-sensing pathway	1.00000000000768	7.68199472136037e-12	63	0	0	22	6908
ko04623	Cytosolic DNA-sensing pathway	1.00000000000768	7.68199472136037e-12	63	0	0	22	6908
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1.00000000000778	7.78495786222044e-12	147	0	0	22	6908
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	1.00000000000778	7.78495786222044e-12	147	0	0	22	6908
ko04320	Dorso-ventral axis formation	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
hsa00053	Ascorbate and aldarate metabolism	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
ko00053	Ascorbate and aldarate metabolism	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
hsa04320	Dorso-ventral axis formation	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
hsa00650	Butanoate metabolism	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
ko00650	Butanoate metabolism	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
ko04966	Collecting duct acid secretion	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
hsa04966	Collecting duct acid secretion	1.00000000000937	9.36887560070079e-12	27	0	0	22	6908
